ABSTRACT
BACKGROUND: This was a head-to-head comparison of two hydrogen-peroxide-based room decontamination systems. AIM: To compare the efficacy, efficiency and safety of hydrogen peroxide vapour (HPV; Clarus R, Bioquell, Andover, U.K.) and aerosolized hydrogen peroxide (aHP; SR2, Sterinis, now supplied as Glosair, Advanced Sterilization Products (ASP), Johnson & Johnson Medical Ltd, Wokingham, U.K.) room disinfection systems. METHOD: Efficacy was tested using 4- and 6-log Geobacillus stearothermophilus biological indicators (BIs) and in-house prepared test discs containing approximately 10(6) meticillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile and Acinetobacter baumannii. Safety was assessed by detecting leakage of hydrogen peroxide using a hand-held detector. Efficiency was assessed by measuring the level of hydrogen peroxide using a hand-held sensor at three locations inside the room, 2 h after the start of the cycles. FINDINGS: HPV generally achieved a 6-log reduction, whereas aHP generally achieved less than a 4-log reduction on the BIs and in-house prepared test discs. Uneven distribution was evident for the aHP system but not the HPV system. Hydrogen peroxide leakage during aHP cycles with the door unsealed, as per the manufacturer's operating manual, exceeded the short-term exposure limit (2 ppm) for more than 2 h. When the door was sealed with tape, as per the HPV system, hydrogen peroxide leakage was <1 ppm for both systems. The mean concentration of hydrogen peroxide in the room 2 h after the cycle started was 1.3 [standard deviation (SD) 0.4] ppm and 2.8 (SD 0.8) ppm for the four HPV and aHP cycles, respectively. None of the readings were <2 ppm for the aHP cycles. CONCLUSION: The HPV system was safer, faster and more effective for biological inactivation.
Subject(s)
Disinfectants , Disinfection/methods , Hydrogen Peroxide , Patients' Rooms , Acinetobacter baumannii/drug effects , Aerosols , Clostridioides difficile/drug effects , Colony Count, Microbial , Disinfectants/adverse effects , Disinfectants/pharmacology , Drosophila Proteins , Geobacillus stearothermophilus/drug effects , Humans , Hydrogen Peroxide/adverse effects , Hydrogen Peroxide/pharmacology , Infection Control/methods , Methicillin-Resistant Staphylococcus aureus/drug effects , Microtubule Proteins , VolatilizationABSTRACT
When treating patients for metastatic cancer, there is always a balance between the benefits of treatment and resulting side-effects. Peripheral sensory neuropathy (PSN) is a side-effect of many anticancer agents used in routine practice. Oxaliplatin is a relatively new agent currently licensed in over 50 countries including France, Germany and the UK for the treatment of metastatic colorectal cancer. Although it is a new agent, it is from the same family of drugs as cisplatin, an agent that has been used for many years. PSN is the most commonly discussed side-effect associated with oxaliplatin. Oxaliplatin-induced PSN is characterized by two distinct syndromes: a transient acute dysaesthesia and a cumulative distal neurotoxicity. Importantly, both are generally reversible after stopping treatment. Oxaliplatin-induced acute PSN is triggered and exacerbated by cold and can be greatly reduced in affected patients simply by avoiding cold conditions. Oxaliplatin-induced cumulative PSN may also be managed by temporary cessation of treatment.
Subject(s)
Antineoplastic Agents , Colorectal Neoplasms/drug therapy , Organoplatinum Compounds , Peripheral Nervous System Diseases , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Disease-Free Survival , Humans , Organoplatinum Compounds/adverse effects , Organoplatinum Compounds/therapeutic use , Oxaliplatin , Peripheral Nervous System Diseases/chemically induced , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/physiopathologyABSTRACT
OBJECTIVE: To study the role of depressogenic medication in the aetiology of major depression in the elderly. BACKGROUND: Depression can be caused, provoked or sustained by drugs prescribed for other reasons. The evidence for this statement is based on case-reports, not on investigations in relevant populations. METHOD: In the geriatric wards of three Dutch psychiatric hospitals, 195 patients with a DSM-III-R diagnosis of major depression (MDD) were studied. In the first week after admission the following data were recorded: age, gender, personal psychiatric history, family psychiatric history, Montgomery-Asberg Depression Rating Scale, Mini-Mental State Examination, history of stroke, use of medication and number of different medications used. Subjects using depressogenic medication were contrasted with subjects not using depressogenic medication on all variables. RESULTS: There was a significant negative relationship, adjusted for the other variables, between the use of depressogenic medication and a previous admission for depression. No other significant relationships between the use of depressogenic medication and aetiological variables were found. Patients with a first-time admission for MDD use depressogenic medication 2.44 times more often than patients with previous admissions for depression. CONCLUSION: The use of depressogenic medication is an independent and clinically relevant aetiological factor in MDD.
Subject(s)
Depressive Disorder, Major/chemically induced , Drug-Related Side Effects and Adverse Reactions , Aged , Depressive Disorder, Major/diagnosis , Female , Humans , Male , Psychiatric Status Rating Scales , Recurrence , Retrospective Studies , Severity of Illness IndexABSTRACT
BACKGROUND: Full recovery rates in naturalistic studies of the treatment of elderly depressives are invariably lower than in clinical trials. This may be the result of inadequate treatment due to lack of clear treatment strategy recommendations for the elderly. METHOD: This is a naturalistic prospective study of depressed elderly in-patients in three Dutch psychiatric hospitals. Patients were included when they suffered from any mood disorder according to DSM-III-R criteria. Severity of the depression was measured on the Montgomery-Asberg Rating Scale. RESULTS: Antidepressants were prescribed to more than 90% of the patients. More than half of them received only one treatment. The dose of the antidepressants was less than the recommended dose for adults in 55% of cases. Full recovery from the depressive episode was achieved in less than half of the patients (33-45%). CONCLUSIONS: In the present study a relatively poor outcome of the antidepressant treatment of elderly depressives has been found. A combination of low treatment expectations and fear of vigorous treatment seems to have been important.
Subject(s)
Antidepressive Agents/therapeutic use , Depressive Disorder/drug therapy , Aged , Aged, 80 and over , Antidepressive Agents/administration & dosage , Dose-Response Relationship, Drug , Drug Combinations , Female , Hospitalization , Humans , Male , Middle Aged , Prospective Studies , Treatment OutcomeSubject(s)
Behavior/drug effects , Dementia/drug therapy , Valproic Acid/therapeutic use , Aged , Aged, 80 and over , Female , Humans , MaleABSTRACT
Ocean models routinely used in simulations of the Earth's climate do not resolve mesoscale eddies because of the immense computational cost. A new parameterization of the effects of these eddies has been implemented in a widely used model. A comparison of its solution with that of the conventional parameterization shows significant improvements in the global temperature distribution, the poleward and surface heat fluxes, and the locations of deep-water formation.
ABSTRACT
Starting from allyl 3-O-benzyl-4,6-O-benzylidene-alpha-D-glucopyranoside as a key intermediate, the following crystalline compounds were prepared: 2-O-allyl-3,4,6-tri-O-benzyl-D-glucopyranose (11) and its p-nitrobenzoate; 2,3,5-tri-O-benzyl-D-arabinofuranose (12) and the corresponding arabinitol; allyl 3,4,6-tri-O-benzyl-alpha-D-glucopyranoside (7); 3,4,6-tri-o-benzyl-D-glucopyranose (8); 2-0-allyl 3, 4-di-o-benzyl-D-glucopyranose (17) and its bis(p-nitrobenzoate); and 3,4-di-O-benzyl-D-glucopyranose (19). The p-nitrobenzoates of compounds 11 and 17 are potential intermediates for the synthesis of the glycolipids of the cytoplasmic membranes of Streptococci.